Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7288
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    79.14
    +0.15 (+0.19%)
     

  • Bitcoin CAD

    84,110.19
    -2,469.45 (-2.85%)
     

  • CMC Crypto 200

    1,303.32
    +8.64 (+0.67%)
     

  • GOLD FUTURES

    2,317.10
    -5.20 (-0.22%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,169.00
    -17.50 (-0.10%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • CAD/EUR

    0.6776
    +0.0005 (+0.07%)
     

Here's Why Tilray's Big News Just Means More of the Same for Investors

Alex Carchidi, The Motley Fool
Updated ·4 min read
Here's Why Tilray's Big News Just Means More of the Same for Investors

On April 10, Tilray Brands (NASDAQ: TLRY) advanced the consolidation of the marijuana industry one step further when it announced that it was acquiring Hexo, an underperforming Canadian cannabis operator. The move should leave the company with a credible claim to being the largest marijuana business in Canada, and it will contribute to Tilray's reputation as being one of the more acquisition-hungry competitors. There are a few things that shareholders likely aren't thrilled about with Tilray's latest purchase, which is expected to close in June.

Continue reading